Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SanOrg34006 in Deep Vein Thrombosis
NCT00067093Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2003
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in deep vein thrombosis (DVT) comparing SanOrg34006 with Standard of Care (2 arms). Primary endpoint: symptomatic recurrent pulmonary embolism or deep vein thrombosis at 3 months. Started May 2003; status: completed.
02
Drugs
idraparinux
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00067093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067093.